Cdiddy, of course an FDA approval for CV would be a huge marker and SP would be off to the races, I am just saying news we are getting now, and good news it is about how well Leronlimab works is already baked into the SP price.

Short of approval the SP will be treading water, the SP range has been set in my opinion, that is why I am mentioning the importance of BLA submission and the believe NP needs to have another resource directly tied to getting the BLA being submitted. Why not have a resource like Kelly sole task to be BLA submission. Your faith in FDA giving us approval for CV is much stronger than mine, It has nothing to do with me knowing Leronlimab works, I am confident of that. Our battle will be with the BP's and FDA. Will so much pressure be put on them (FDA) that they finally give in and approve since results will be overwhelming ? That is yet to be seen.